363 related articles for article (PubMed ID: 30108008)
21. In-hospital versus postdischarge major adverse events within 30 days following lower extremity revascularization.
Liang P; Li C; O'Donnell TFX; Lo RC; Soden PA; Swerdlow NJ; Schermerhorn ML
J Vasc Surg; 2019 Feb; 69(2):482-489. PubMed ID: 30301689
[TBL] [Abstract][Full Text] [Related]
22. Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft.
Sachs T; Pomposelli F; Hamdan A; Wyers M; Schermerhorn M
J Vasc Surg; 2011 Oct; 54(4):1021-1031.e1. PubMed ID: 21880457
[TBL] [Abstract][Full Text] [Related]
23. A systematic review of treatment of intermittent claudication in the lower extremities.
Malgor RD; Alahdab F; Elraiyah TA; Rizvi AZ; Lane MA; Prokop LJ; Phung OJ; Farah W; Montori VM; Conte MS; Murad MH
J Vasc Surg; 2015 Mar; 61(3 Suppl):54S-73S. PubMed ID: 25721067
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of lower extremity peripheral artery disease in veterans.
Willey J; Mentias A; Vaughan-Sarrazin M; McCoy K; Rosenthal G; Girotra S
J Vasc Surg; 2018 Aug; 68(2):527-535.e5. PubMed ID: 29588132
[TBL] [Abstract][Full Text] [Related]
25. Understanding Patient Acceptance of Risk with Treatment Options for Intermittent Claudication.
Morbi AHM; Coles S; Albayati M; Nordon IM; Shearman C
Ann Vasc Surg; 2017 Apr; 40():223-230. PubMed ID: 27908805
[TBL] [Abstract][Full Text] [Related]
26. Revascularization of smokers with claudication is not predicted to limit quality of life despite a higher risk of late failure.
Mixson JD; Brothers TE
J Vasc Surg; 2017 Jan; 65(1):128-135.e1. PubMed ID: 27687324
[TBL] [Abstract][Full Text] [Related]
27. Statin use improves limb salvage after intervention for peripheral arterial disease.
Parmar GM; Novak Z; Spangler E; Patterson M; Passman MA; Beck AW; Pearce BJ
J Vasc Surg; 2019 Aug; 70(2):539-546. PubMed ID: 30718113
[TBL] [Abstract][Full Text] [Related]
28. Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).
Kiesz RS; Wiernek SL; Wiernek BK; Radvany MG; Buszman PP; Szymanski R; Konkolewska MD; Martin JL; Buszman PE
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E244-50. PubMed ID: 23172729
[TBL] [Abstract][Full Text] [Related]
29. Cilostazol and freedom from amputation after lower extremity revascularization.
Neel JD; Kruse RL; Dombrovskiy VY; Vogel TR
J Vasc Surg; 2015 Apr; 61(4):960-4. PubMed ID: 25595396
[TBL] [Abstract][Full Text] [Related]
30. Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia.
Ramanan B; Jeon-Slaughter H; Chen X; Kashyap VS; Kirkwood ML; Timaran CH; Modrall JG; Tsai S
J Vasc Surg; 2021 Oct; 74(4):1327-1334. PubMed ID: 34023428
[TBL] [Abstract][Full Text] [Related]
31. Reinterventions in Patients with Claudication and Chronic Limb Threatening Ischemia.
Mohamedali A; Kiwan G; Kim T; Zhang Y; Zhuo H; Tonnessen B; Dardik A; Chaar CIO
Ann Vasc Surg; 2022 Feb; 79():56-64. PubMed ID: 34656724
[TBL] [Abstract][Full Text] [Related]
32. Statin use and other factors associated with mortality after major lower extremity amputation.
DeCarlo C; Scher L; Shariff S; Phair J; Lipsitz E; Garg K
J Vasc Surg; 2017 Jul; 66(1):216-225. PubMed ID: 28431865
[TBL] [Abstract][Full Text] [Related]
33. Preoperative statins and limb salvage after lower extremity revascularization in the Medicare population.
Vogel TR; Dombrovskiy VY; Galiñanes EL; Kruse RL
Circ Cardiovasc Interv; 2013 Dec; 6(6):694-700. PubMed ID: 24300135
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes after lower extremity bypass in the actively smoking claudicant.
Patel RJ; Zarrintan S; Jagadeesh V; Vootukuru NR; Gaffey A; Malas MB
J Vasc Surg; 2023 Oct; 78(4):1003-1011. PubMed ID: 37327952
[TBL] [Abstract][Full Text] [Related]
35. Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009.
Loja MN; Brunson A; Li CS; Carson JG; White RH; Romano PS; Hedayati N
Ann Vasc Surg; 2015 Jul; 29(5):950-9. PubMed ID: 25757991
[TBL] [Abstract][Full Text] [Related]
36. Distal embolization during lower extremity endovascular interventions.
Ochoa Chaar CI; Shebl F; Sumpio B; Dardik A; Indes J; Sarac T
J Vasc Surg; 2017 Jul; 66(1):143-150. PubMed ID: 28366300
[TBL] [Abstract][Full Text] [Related]
37. Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization.
Kray JE; Dombrovskiy VY; Vogel TR
Vasc Health Risk Manag; 2017; 13():269-274. PubMed ID: 28761352
[TBL] [Abstract][Full Text] [Related]
38. Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.
Bodewes TCF; Ultee KHJ; Soden PA; Zettervall SL; Shean KE; Jones DW; Moll FL; Schermerhorn ML
J Vasc Surg; 2017 May; 65(5):1354-1365.e2. PubMed ID: 28190717
[TBL] [Abstract][Full Text] [Related]
39. Prescribing of Statins After Lower Extremity Revascularization Procedures in the US.
Singh N; Ding L; Devera J; Magee GA; Garg PK
JAMA Netw Open; 2021 Dec; 4(12):e2136014. PubMed ID: 34860245
[TBL] [Abstract][Full Text] [Related]
40. Elective infrainguinal lower extremity bypass for claudication is associated with high postoperative intensive care utilization.
Alshaikh HN; Hicks CW; DiBrito SR; Zarkowsky DS; Siracuse JJ; Malas MB
J Vasc Surg; 2019 Jun; 69(6):1863-1873.e1. PubMed ID: 31159987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
